Pharmafile Logo
Pharmafocus logo
Advanced Search

Novasep expands in China, raises €40m for investments

April 3, 2012
Manufacturing and Production China, Novasep, Shanghai, manufacturing

French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …

News

Pharma manufacturing news in brief

April 3, 2012
Manufacturing and Production Gerresheimer and Foster Wheeler, Pharmax, Sigma-Aldrich

Pharmax starts building Dubai plant, Brazil tightens gelatin controls, plus updates from Sigma-Aldrich, Gerresheimer and Foster Wheeler.

News

Michael Cola resigns from Shire

April 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire

Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm.  “On behalf of …

Appointment
Halaven image

NICE rejects Halaven for breast cancer

April 3, 2012
Sales and Marketing Eisai, Halaven, NICE, breast cancer

NICE has rejected Eisai’s novel breast cancer drug Halaven, due to concerns over its safety and costs.  In its final …

News

Moving Towards a Risk-Based approach to Clinical Trial Management

April 3, 2012
Research and Development

Clinical trials need to be managed to rigorous standards in order to secure the quality and integrity of every aspect …

Feature
Thought Leadership

Universal WorldEvents Marks Anniversary with Increase in Events

April 2, 2012
Sales and Marketing

Universal WorldEvents has marked its first anniversary by revealing a significant increase in the number of events organised by the …

News
Press release

Novartis to construct pharma plant in Turkey

April 2, 2012
Manufacturing and Production Novartis, Turkey, manufacturing

Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …

News

AstraZeneca wins fresh US victory with Seroquel XR

April 2, 2012
Sales and Marketing AZ, AstraZeneca, FDA, Seroquel XR

AstraZeneca is celebrating a US court verdict in its ongoing battle for intellectual property over the extended release version of …

News

Piramal opens ADC plant in Scotland

April 2, 2012
Manufacturing and Production ADC, Abbott, Piramel

India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …

News
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

News
Roche image

Roche raises Illumina bid to $6.7 billion

April 2, 2012
Sales and Marketing

Roche has increased its takeover bid for Illumina, with the offer now valuing the company at $6.7 billion.The firm makes …

News
Teva image

Teva sells Canadian plant to CMO

March 30, 2012
Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing

Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …

News

Amylin dismisses BMS acquisition deal

March 30, 2012
Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly

Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …

News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …

Appointment
NICE image

NICE recommends Xgeva for bone metastasis

March 29, 2012
Sales and Marketing Amgen, NICE, Xgeva, Zytiga, denosumab, prostate cancer

NICE has issued draft guidance recommending Amgen’s Xgeva (denosumab) for certain groups of cancer patients whose disease has spread to …

News

Approval for Affymax and Takeda’s anaemia treatment

March 29, 2012
Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys

The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …

News
a_mahmoud

Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud

March 29, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines

Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors.  Mahmoud, a global infectious …

Appointment

Prostate cancer drug extends life after chemotherapy

March 29, 2012
Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer

Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …

News
Psoriasis Facebook image

Janssen to remove its Psoriasis 360 Facebook page

March 28, 2012
Medical Communications Facebook, Janssen, PM Soc, Psoriasis 360

Janssen has decided to take down its award-winning Psoriasis 360 page on Facebook, citing an increasing amount of troublesome comments. …

News

Omnicom Group chooses CAHG as its lead healthcare agency

March 28, 2012
Medical Communications CAHG. TBWA, Omnicom, WorldHealth

The Omnicom Group has chosen its healthcare comms agency CAHG to form a strategic alliance with TBWA\WorldHealth as the company’s …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026